Abstract
Treatment with the anti-tumour necrosis factor alpha monoclonal antibody infliximab has been shown to be effective in moderate-to-severe ulcerative colitis. However, its effect on the mucosal histopathological abnormalities of this disease is largely unknown. This study aimed to assess the immunohistological effect of infliximab in ulcerative colitis.
Lingua originale | English |
---|---|
pagine (da-a) | 811-817 |
Numero di pagine | 7 |
Rivista | Digestive and Liver Disease |
Volume | 39 |
DOI | |
Stato di pubblicazione | Pubblicato - 2007 |
Pubblicato esternamente | Sì |
Keywords
- Adult
- Aged
- Antibodies, Monoclonal
- Colitis, Ulcerative
- Down-Regulation
- Female
- Humans
- Immunologic Factors
- Inflammation
- Male
- Middle Aged
- Tumor Necrosis Factor-alpha